1
|
Spiro RH: Salivary neoplasms: overview of
a 35-year experience with 2,807 patients. Head Neck Surg.
8:177–184. 1986.
|
2
|
Carrillo JF, Vázquez R, Ramírez-Ortega MC,
et al: Multivariate prediction of the probability of recurrence in
patients with carcinoma of the parotid gland. Cancer.
109:2043–2051. 2007.
|
3
|
Bhattacharyya N and Fried MP: Nodal
metastasis in major salivary gland cancer: predictive factors and
effects on survival. Arch Otolaryngol Head Neck Surg. 128:904–908.
2002.
|
4
|
Régis De Brito Santos I, Kowalski LP,
Cavalcante De Araujo V, Flávia Logullo A and Magrin J: Multivariate
analysis of risk factors for neck metastases in surgically treated
parotid carcinomas. Arch Otolaryngol Head Neck Surg. 127:56–60.
2001.
|
5
|
Medina JE: Neck dissection in the
treatment of cancer of major salivary glands. Otolaryngol Clin
North Am. 31:815–822. 1998.
|
6
|
Kawata R, Koutetsu L, Yoshimura K,
Nishikawa S and Takenaka H: Indication for elective neck dissection
for N0 carcinoma of the parotid gland: a single institution’s
20-year experience. Acta Otolaryngol. 130:286–292. 2010.
|
7
|
National Comprehensive Cancer Network.
Clinical Practice Guidelines in Oncology™ Head and Neck Cancer
Version 1.2012. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
Accessed April 26, 2012
|
8
|
Hocwald E, Korkmaz H, Yoo GH, et al:
Prognostic factors in major salivary gland cancer. Laryngoscope.
111:1434–1439. 2001.
|
9
|
Lima RA, Tavares MR, Dias FL, et al:
Clinical prognostic factors in malignant parotid gland tumors.
Otolaryngol Head Neck Surg. 133:702–708. 2005.
|
10
|
Spiro RH, Huvos AG, Berk R and Strong EW:
Mucoepidermoid carcinoma of salivary gland origin. A
clinicopathologic study of 367 cases. Am J Surg. 136:461–468.
1978.
|
11
|
Hicks MJ, el-Naggar AK, Flaitz CM, Luna MA
and Batsakis JG: Histocytologic grading of mucoepidermoid carcinoma
of major salivary glands in prognosis and survival: a
clinicopathologic and flow cytometric investigation. Head Neck.
17:89–95. 1995.
|
12
|
Frankenthaler RA, Luna MA, Lee SS, et al:
Prognostic variables in parotid gland cancer. Arch Otolaryngol Head
Neck Surg. 117:1251–1256. 1991.
|
13
|
Armstrong JG, Harrison LB, Thaler HT, et
al: The indications for elective treatment of the neck in cancer of
the major salivary glands. Cancer. 69:615–619. 1992.
|
14
|
Kelley DJ and Spiro RH: Management of the
neck in parotid carcinoma. Am J Surg. 172:695–697. 1996.
|
15
|
Stodulski D, Mikaszewski B and Stankiewicz
C: Signs and symptoms of parotid gland carcinoma and their
prognostic value. Int J Oral Maxillofac Surg. 41:801–806. 2012.
|
16
|
Pohar S, Gay H, Rosenbaum P, et al:
Malignant parotid tumors: presentation, clinical/pathologic
prognostic factors, and treatment outcomes. Int J Radiat Oncol Biol
Phys. 61:112–118. 2005.
|
17
|
Rafla S: Malignant parotid tumors: natural
history and treatment. Cancer. 40:136–144. 1977.
|
18
|
Fordice J, Kershaw C, El-Naggar A and
Goepfert H: Adenoid cystic carcinoma of the head and neck:
predictors of morbidity and mortality. Arch Otolaryngol Head Neck
Surg. 125:149–152. 1999.
|
19
|
Pedersen D, Overgaard J, Søgaard H,
Elbrønd O and Overgaard M: Malignant parotid tumors in 110
consecutive patients: treatment results and prognosis.
Laryngoscope. 102:1064–1069. 1992.
|
20
|
Therkildsen MH, Christensen M, Andersen
LJ, Schiødt T and Hansen HS: Salivary gland carcinomas - prognostic
factors. Acta Oncol. 37:701–713. 1998.
|